| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |